Dynamic Biotechnology & Genome Intellidex Index ETF Overview

With 1 ETFs traded in the U.S. markets, Dynamic Biotechnology & Genome Intellidex Index ETFs gather total assets under management of $279.97M. The average expense ratio is 0.59%. Dynamic Biotechnology & Genome Intellidex Index ETFs can be found in the following asset classes:

  • Equity

Features and News

Worst Performing ETFs Of 2016 To Date

It's still early in the year, but a number of ETFs have already lost 25-50% of their value in 2016.

ETF Report

 Best & Worst Smart Beta ETFs

A look at which ‘smart beta’ funds are top and bottom performers so far this year.

Features and News

Best & Worst Smart Beta ETFs

A look at which ‘smart beta’ funds are top and bottom performers so far this year.

Features and News

Want To Grow? Keep ETF Share Price Low

One market expert suggests it may be time for share splits in the largest ETFs.

Features and News

10 Best Performing ETFs Year To Date

So far in 2014, India, coffee, biotech and long-dated Treasurys have been good to investors.

Features and News

4 Biotech ETFs Beating S&P 500

Biotech ETFs are defying predictions that small-cap stocks are likely to be under pressure.

Features and News

4 Of The Biggest Risks Related To ETFs

Looking under the hood of any fund you own can prevent a lot of surprises.

Features and News

Best ETFs In 2013: DBJP, Tesla-Fueled QCLN

The latest tally of year-to-date top-10-performing ETFs include Japan, clean energy and biotech funds, to name a few.

ETF.com Analysis

Biotech ETFs: Not All Equal

Biotech is a red-hot sector, but if you're not looking you could end up in a lukewarm fund.